Tech Company M&A Transactions
Raven Biotechnologies Acquisition
Raven Biotechnologies was bought by MacroGenics. The transaction was announced on 7/17/2008. The financial terms of the deal were not announced.
Transaction Overview
Company Name
Acquired By
Announced On
7/17/2008
Transaction Type
M&A
Amount
Unknown
M&A Terms
MacroGenics will issue shares of its stock to purchase Raven. Other terms of the transaction were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
One Corporate Drive
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Raven's approach creates the optimal starting point for developing a new drug with an increased probability of success in the clinic, within a substantially compressed time frame for drug lead development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
George Schreiner
Chief Operating Officer
John Whelan
Chief Scientific Officer
Jennie Mather
Vice President
Carolyn Adler
Vice President
Stanford Stewart
VP - Manufacturing
Lucille Chang
Browse more venture capital transactions:
Prev: 7/17/2008: Slingpage venture capital transaction
Next: 7/17/2008: Business Insider venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs